Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
9.09
0.00 (0.00%)
Feb 13, 2026, 4:00 PM EST - Market closed
Sensei Biotherapeutics Market Cap
Sensei Biotherapeutics has a market cap or net worth of $11.47 million as of February 13, 2026. Its market cap has decreased by -4.81% in one year.
Market Cap
11.47M
Enterprise Value
-11.55M
1-Year Change
-4.81%
Ranking
Category
Stock Price
$9.09
Market Cap Chart
Since the IPO on February 4, 2021, Sensei Biotherapeutics's market cap has decreased from $561.61M to $11.47M, a decrease of -97.96%. That is a compound annual growth rate of -53.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.47M | -14.81% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.40% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 12.45M |
| GT Biopharma | 12.36M |
| BioCardia | 12.10M |
| CytoMed Therapeutics | 11.77M |
| KALA BIO | 11.48M |
| Longeveron | 11.43M |
| BioAtla | 11.14M |
| Quince Therapeutics | 11.14M |